HAE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Haemonetics Corp's quarterly cash and cash equivalents increased from Sep. 2013 ($159.1 Mil) to Dec. 2013 ($177.8 Mil) and increased from Dec. 2013 ($177.8 Mil) to Mar. 2014 ($192.5 Mil).
Haemonetics Corp's annual cash and cash equivalents declined from Mar. 2012 ($228.9 Mil) to Mar. 2013 ($179.1 Mil) but then increased from Mar. 2013 ($179.1 Mil) to Mar. 2014 ($192.5 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Haemonetics Corp Annual Data
Haemonetics Corp Quarterly Data